{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:55:17Z","timestamp":1781571317508,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xkme.2025.101165","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:01:29Z","timestamp":1762315289000},"page":"101165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rifampin-induced Acute Kidney Injury Is Associated With Hemolysis and Drug Re-exposure"],"prefix":"10.1016","volume":"8","author":[{"given":"Junaid A.","family":"Wali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen A.","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Al-Kawaaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Troxell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1016\/j.xkme.2025.101165_bib1","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1093\/clinids\/5.Supplement_3.S402","article-title":"History of the development of rifampin","volume":"5","author":"Sensi","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"995","key":"10.1016\/j.xkme.2025.101165_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/207417a0","article-title":"Effect of rifamycin on protein synthesis","volume":"207","author":"Calvori","year":"1965","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.xkme.2025.101165_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000091839","article-title":"Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance","volume":"140","author":"Buergin","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101165_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bjid.2013.08.001","article-title":"Rifampin induced angioedema: a rare but serious side effect","volume":"18","author":"Mirsaeidi","year":"2014","journal-title":"Braz J Infect Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2012.11-0598","article-title":"Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin","volume":"86","author":"Havey","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.xkme.2025.101165_bib8","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.927586","article-title":"Rifampicin-induced pneumonitis mimicking severe COVID-19 pneumonia infection","volume":"21","author":"Ata","year":"2020","journal-title":"Am J Case Rep"},{"issue":"4","key":"10.1016\/j.xkme.2025.101165_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2169\/internalmedicine.0813-18","article-title":"A case series of acute kidney injury during anti-tuberculosis treatment","volume":"58","author":"Sakashita","year":"2019","journal-title":"Intern Med"},{"key":"10.1016\/j.xkme.2025.101165_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-14-23","article-title":"Acute kidney injury due to anti-tuberculosis drugs: a five-year experience in an aging population","volume":"14","author":"Chang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.xkme.2025.101165_bib11","article-title":"Rifampicin in nontuberculous mycobacterial infections: acute kidney injury with hemoglobin casts","volume":"2018","author":"Kora","year":"2018","journal-title":"Case Rep Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101165_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/13.4.924","article-title":"Rifampicin-induced acute renal failure: a series of 60 patients","volume":"13","author":"Covic","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2025.101165_bib13","first-page":"20","article-title":"A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases","volume":"102","author":"Covic","year":"2004","journal-title":"J Indian Med Assoc"},{"issue":"4","key":"10.1016\/j.xkme.2025.101165_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/ajkd.2002.35675","article-title":"Acute renal failure due to rifampicin: a study of 25 patients","volume":"40","author":"Muthukumar","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2025.101165_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/ajkd.1998.v31.pm9428460","article-title":"Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features","volume":"31","author":"De Vriese","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"7-8","key":"10.1016\/j.xkme.2025.101165_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/106002809102500709","article-title":"Acute hemolysis and renal failure following discontinuous use of rifampin","volume":"25","author":"Levine","year":"1991","journal-title":"DICP"},{"issue":"12","key":"10.1016\/j.xkme.2025.101165_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6780","article-title":"Rifampin-induced acute kidney injury and hemolysis: A case report and literature review of a rare condition","volume":"10","author":"Ata","year":"2022","journal-title":"Clin Case Rep"},{"issue":"7","key":"10.1016\/j.xkme.2025.101165_bib18","article-title":"Rifampin-induced acute intravascular hemolysis leading to heme pigment-related kidney injury","volume":"12","author":"Sanwal","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.xkme.2025.101165_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pulmoe.2020.04.006","article-title":"Rifampicin-induced disseminated intravascular coagulation: an antibody-mediated side effect","volume":"27","author":"Sousa","year":"2021","journal-title":"Pulmonology"},{"issue":"7","key":"10.1016\/j.xkme.2025.101165_bib20","doi-asserted-by":"crossref","first-page":"ofac258","DOI":"10.1093\/ofid\/ofac258","article-title":"Acute tubular necrosis and thrombocytopenia associated with rifampin use: case report and review","volume":"9","author":"Smith","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2141.2002.03416.x","article-title":"Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia","volume":"117","author":"Ahrens","year":"2002","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.xkme.2025.101165_bib22","first-page":"1179","article-title":"Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication Ren Fail","volume":"35","author":"Manika","year":"2013"},{"issue":"6","key":"10.1016\/j.xkme.2025.101165_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5414\/CNP73413","article-title":"Acute tubulointerstitial nephritis related to antituberculous drug therapy","volume":"73","author":"Schubert","year":"2010","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2025.101165_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.xkme.2025.101165_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.xkme.2025.101165_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.1190","article-title":"Rifampicin-induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: a case report","volume":"11","author":"Moussa","year":"2023","journal-title":"Respirol Case Rep"},{"issue":"3","key":"10.1016\/j.xkme.2025.101165_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ckj\/sfx121","article-title":"Clinical profile and outcome of pigment-induced nephropathy","volume":"11","author":"Sakthirajan","year":"2018","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.xkme.2025.101165_bib28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.kint.2019.08.026","article-title":"Hemolysis-associated hemoglobin cast nephropathy results from a range of clinicopathologic disorders","volume":"96","author":"Dvanajscak","year":"2019","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3349\/ymj.2015.56.2.582","article-title":"Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy","volume":"56","author":"Park","year":"2015","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.xkme.2025.101165_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1309\/AJCPBVLJZH6W6RQM","article-title":"Pathology consultation on drug-induced hemolytic anemia","volume":"136","author":"Pierce","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000525561","article-title":"Facing the challenge of drug-induced acute interstitial nephritis","volume":"147","author":"Sanchez-Alamo","year":"2023","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.xkme.2025.101165_bib32","article-title":"Rifampin-associated renal failure","volume":"2","author":"Miller","year":"2023","journal-title":"Ann Intern Med Clin Cases"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.25259\/NMJI_1479_2024","article-title":"Rifampicin-associated intravascular haemolysis causing acute kidney injury","volume":"38","author":"Aravindhmozhi","year":"2025","journal-title":"Natl Med J India"},{"issue":"3","key":"10.1016\/j.xkme.2025.101165_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/path.6284","article-title":"Megalin-related mechanism of hemolysis-induced acute kidney injury and the therapeutic strategy","volume":"263","author":"Goto","year":"2024","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101165_bib35","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood.V95.6.1988","article-title":"Rifampicin-dependent antibodies bind a similar or identical epitope to glycoprotein IX-specific quinine-dependent antibodies","volume":"95","author":"Burgess","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.xkme.2025.101165_bib36","first-page":"276","article-title":"Identification of I\/i, Pr1-3 and Gd antigens in the human kidney: possible relevance to hyperacute graft rejection induced by cold agglutinins","volume":"33","author":"Lenhard","year":"1978","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101165_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","volume":"2009","author":"Garratty","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.xkme.2025.101165_bib38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5588\/ijtld.23.0078","article-title":"Clinical standards for the management of adverse effects during treatment for TB","volume":"27","author":"Singh","year":"2023","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:35:25Z","timestamp":1781570125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525002018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2590059525002018"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101165","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifampin-induced Acute Kidney Injury Is Associated With Hemolysis and Drug Re-exposure","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101165"}}